Also known as: piper methysticum, kava kava
Latest evidence update: 2024-12-15
Strongest in Study quality (71). Held back by Recency (19).
Solid mix of RCTs with some methodological gaps.
Good cross-study replication, some imprecision.
Thousands of participants across the literature.
Mostly aligned, with some divergence.
Mostly pre-2020 research; updates may be needed.
No quantified outcomes for Kavayet. Once the corpus has studies with measurable endpoints, you'll see per-outcome magnitude here.
Recommended: Not recommended without supervision
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.
Reduces anxiety symptoms in people with generalized anxiety disorder
Does not impair driving ability or cognitive performance at typical doses
Is not effective for treating insomnia and is not recommended for this use
Is well tolerated with minimal side effects at recommended doses for short-term use
May improve sexual function and drive in people with anxiety